Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Clinical trial NCT03447808 · COMPLETED

Trial details

NCT number: NCT03447808
Sponsor: Jennifer Woyach
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2018-08-16
Primary completion: 2026-05-26
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.